EMMUNE, INC

Organization

JUPITER, FL, US

Organizations

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
SCAFFOLDED ANTIGENS AND ENGINEERED SARS-COV-2 RECEPTOR-BINDING DOMA...
- Publication number 20230414748
- Publication date Dec 28, 2023
- EMMUNE, INC.
- Michael Farzan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACE2 MUTEINS AND METHODS OF USING THE SAME
- Publication number 20230183668
- Publication date Jun 15, 2023
- EMMUNE, INC.
- Charles C. Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD4 MUTEINS AND METHODS OF USING THE SAME
- Publication number 20230159616
- Publication date May 25, 2023
- UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED
- Michael Farzan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

NIH Research Projectlast 12 months

processing...

Count: 13

Research Projects

Information Research Project
Glycoengineering eCD4-Ig
- Application id 10326424
- Award notice date Jul 13, 2021
Information Research Project
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
- Application id 10167626
- Award notice date Apr 16, 2021
Information Research Project
Engineering AAV capsids for enhanced transduction of skeletal muscle
- Application id 10290483
- Award notice date Jan 25, 2021
Information Research Project
Engineering AAV capsids for enhanced transduction of skeletal muscle
- Application id 10080465
- Award notice date Aug 18, 2020
Information Research Project
Development of AAV vectors for long-term expression of eCD4-Ig
- Application id 9979748
- Award notice date Jul 20, 2020
Information Research Project
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
- Application id 10124477
- Award notice date May 19, 2020
Information Research Project
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
- Application id 9847059
- Award notice date Jul 30, 2019
Information Research Project
Development of AAV vectors for long-term expression of eCD4-Ig
- Application id 9770769
- Award notice date Jul 17, 2019
Information Research Project
Development of AAV vectors for long-term expression of eCD4-Ig
- Application id 9749347
- Award notice date Aug 27, 2018
Information Research Project
WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICAT...
- Application id 9429040
- Award notice date Jan 30, 2018
Information Research Project
Cpf1-mediated inactivation of an AAV transgene
- Application id 9466481
- Award notice date Jan 5, 2018
Information Research Project
Development of AAV vectors for long-term expression of eCD4-Ig
- Application id 9410355
- Award notice date Jul 25, 2017
Information Research Project
WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICAT...
- Application id 9390589
- Award notice date Feb 9, 2017

EMMUNE, INC

Organization

Patents Applicationslast 30 patents

SCAFFOLDED ANTIGENS AND ENGINEERED SARS-COV-2 RECEPTOR-BINDING DOMA...

ACE2 MUTEINS AND METHODS OF USING THE SAME

CD4 MUTEINS AND METHODS OF USING THE SAME

NIH Research Projectlast 12 months

Research Projects

Glycoengineering eCD4-Ig

Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig

Engineering AAV capsids for enhanced transduction of skeletal muscle

Engineering AAV capsids for enhanced transduction of skeletal muscle

Development of AAV vectors for long-term expression of eCD4-Ig

Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig

Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig

Development of AAV vectors for long-term expression of eCD4-Ig

Development of AAV vectors for long-term expression of eCD4-Ig

WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICAT...

Cpf1-mediated inactivation of an AAV transgene

Development of AAV vectors for long-term expression of eCD4-Ig

WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICAT...